MINNEAPOLIS, July 23, 2014 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that the Company has obtained regulatory CE mark for integrating the next generation MRI core technology into the VISIUS® Surgical Theatre allowing for sales and marketing in the European Union.